CoChat

Incretin‐Based Therapies for Type 2 Diabetes Mellitus: Current Status and Future Prospects

Drab, Scott R. · 2010 · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Cited by 51

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Incretin‐based therapies encompass two new classes of antidiabetic drugs: glucagon‐like peptide‐1 (GLP‐l) receptor agonists (e.g., liraglutide, exenatide, and exenatide long‐acting release), which are structurally related to GLP‐l, and the dipeptidyl peptidase‐4 (DPP‐4) inhibitors (e.g., sitagliptin and saxagliptin), which limit the breakdown of endogenous GLP‐l. To evaluate the safety and effectiveness of incretin‐based therapies for the treatment of type 2 diabetes mellitus and the role of these therapies in clinical practice, a MEDLINE search (January 1985‐November 2009) was conducted. Relevant references from the publications identified were also reviewed. Of 28 studies identified, 22 were randomized controlled trials. Data show that these therapies affect insulin secretion in a glucose‐dependent manner, achieving clinically meaningful reductions in hemoglobin A 1c levels, with very low rates of hypoglycemia. In addition, reductions in body weight have been observed with GLP‐l receptor agonists, which also exert a pronounced effect on systolic blood pressure. Various human and animal studies show that GLP‐l improves β‐cell function and increases β‐cell proliferation in vitro, which may slow disease progression. Thus, incretin‐based therapies represent a promising addition to the available treatments for type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1592/phco.30.6.609

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 51

Metadata

Authors
Drab, S. R.
Venue
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Publisher
Wiley
Published
2010-06
Volume
30
Issue
6
Pages
609-624
ISSN
  • 0277-0008 (ISSN-L)
  • 1875-9114
OpenAlex
W2050938327
Cited by
51
References
47
FWCI
7.27
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.